Diagnostic service

Hereditary Cancer Screening

Genetic testing to help assess inherited breast and ovarian cancer risk, supporting early detection and informed care.

Technical Parameters

Target Genes
BRCA1, BRCA2 & Inherited Panels
Technology
DNA Sequencing & Mutational Profiling
Sample Required
Peripheral Blood / EDTA Sample
Clinical Goal
Familial Cancer Risk Stratification
Lead Researcher & Team
Dr. Mariam Shahid and Genetic Screening team

Application Areas

Clinical OncologyHereditary Breast & Ovarian CancerEarly Risk StratificationGenetic Counselling Support
Genetic Screening Research Group

Investigating complex disease genetics and providing precision molecular screening services.

Evidence led

Validated
methodology

CEMB quality

Research
you can trust

Practical impact

From lab
to real life

Original CEMB material for Hereditary Cancer Screening
Trusted CEMB research & services

Why it matters

Scientific Significance & Real-World Value

CEMB's genetic screening service helps assess inherited risk for breast and ovarian cancer, using DNA analysis to identify pathogenic variants associated with hereditary cancer syndromes.

Results are intended to support informed clinical decision-making alongside genetic counselling, not to replace a full clinical evaluation.

Evidence-led outcome

Genetic testing to help assess inherited breast and ovarian cancer risk, supporting early detection and informed care.

Core Benefits at a Glance

  • DNA-based hereditary risk assessment
  • Supports early detection and preventive care planning
  • Findings should be interpreted with genetic counselling

Partner with CEMB for Molecular Innovation

Driving research. Delivering accuracy. Building a healthier future.

Start a Collaboration